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What is already known about this subject 
• Lower adiponectin levels are associated with concomitant cardiometabolic 
alterations, regardless of adiposity. 
• Controlling for BMI, both intrauterine weight gain and weight gain during the first 
months of life are inversely and independently associated with later adiponectin 
levels.  
• Among small-for-gestational-age infants, formula fed infants have lower 
adiponectin levels at 12 months of age compared to breastfed infants.  
What this study adds 
• Weight gain during the first months of life was inversely and independently 
associated with adolescent adiponectin levels, controlling for fat mass and other 
covariates. 
• For normal weight infants, breastfeeding as the sole source of milk for 6 months or 
more was associated with greater adolescent adiponectin levels.  
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Abstract 
Background. Early life factors can program future risk for cardiovascular disease.  
Objective. We explored associations between adolescent adiponectin levels and 
concomitant metabolic alteration, and also looked at the association between early life 
factors and adolescent adiponectin levels. 
Methods. We studied a longitudinal cohort of low- to middle-income Chilean adolescents 
who were enrolled in an infancy iron deficiency anemia preventive trial and follow-up 
studies at the Institute of Nutrition and Food Technology, University of Chile, Santiago, 
Chile. In 577 adolescents who were assessed as part of the 16y follow-up, we evaluated 
independent associations between adiponectin levels and metabolic disturbances during 
adolescence. We also assessed the association between early life factors (short 
breastfeeding (˂ 6 months) and infancy weight gain) and adolescent adiponectin levels. 
Results. Participants were 16.8 year-old (16.4-18.1), 48% female and 38% 
overweight/obese. Adolescent adiponectin levels were inversely associated with metabolic 
disturbances: altered homeostatic model assessment of insulin resistance and high-density 
lipoprotein cholesterol (ORs [95%CI]= 0.87 [0.79-0.95], p-value=0.002 and 0.90 [0.87-
0.94], p-value<0.001, respectively), adjusting for sex and fat mass index. Early life factors 
were independently associated with adolescent adiponectin levels, which decreased 0.88 
ug/mL per each unit increase in weight-for-age z-score between 0 and 6 months, and was 
1.58 ug/mL lower among participants with short breastfeeding.   
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Conclusions. Higher adolescent adiponectin levels were independently associated with 
lower odds of metabolic disturbances. Greater weight gain during infancy and shorter 
breastfeeding were associated with lower adolescent adiponectin levels, supporting research 
indicating early life as a window of opportunity for prevention of later cardiovascular 
alterations. 
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Introduction 
As obesity prevalence continues to rise, cardiometabolic disturbances associated 
with excess fat mass have become important health and economic burdens facing both 
developed and developing nations (1). Children and adolescents are not immune to health 
impairments associated with obesity, which could result in important reductions in healthy 
lifespan (2). However, about 25-35% of people are discordant in terms of adipose tissue 
(AT) amount and metabolic consequences, i.e., obese individuals metabolically healthy or 
normal weight individuals with metabolic alterations (3). Some AT features such as the 
topography or the adipokine secretory profile, may explain the discordancy (4, 5). 
Specifically, the ability to secrete adiponectin is a key feature, since adiponectin is an 
insulin-sensitizing and cardioprotective hormone that improves the metabolism of lipids 
and carbohydrates and has anti-inflammatory effects (6). Its levels have been associated 
with cardiometabolic parameters, independent of adiposity (7, 8), and has been implicated 
in discordant adiposity-metabolic profiles in both obese and normal weight participants (9). 
Low adiponectin has also been shown to independently predict metabolic alterations among 
children and adolescents (10, 11). Several factors at the cellular or tissue level have been 
implicated in poor adiponectin secretion (12). However, the causes for the development of 
such factors are not well understood and therefore cannot be targeted.  
It has been suggested that events in early life might influence adiponectin levels (10, 
13-15). At least two prior studies have shown that infancy weight gain correlates to later 
adiponectin levels (10, 14). In addition, prior research has shown relationships between 
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early nutrition and leptin (16). The hypothesis that early life factors relate to adiponectin is 
in line with the developmental origin of health and diseases concept. In a group of healthy 
adolescents who were part of a cohort followed since infancy, we aimed to 1) confirm 
previous findings regarding the associations between adolescent adiponectin levels and 
concomitant metabolic alterations, regardless of adiposity and sex and 2) to explore 
potential effects of early life factors on adolescent adiponectin levels.  
 
Methods 
 
Study design. The sample is from a longitudinal study, which began as an infancy 
iron deficiency anemia preventive trial in Santiago, Chile (1991-1996; total n=1657) (17). 
Infants were screened at community clinics to enroll healthy, singleton full-term infants, 
with birthweights ≥3 kg, who did not have iron-deficiency anemia at 6 months. The infants 
were randomized to high iron or low iron supplementation or usual nutrition. The 
participants were subsequently followed at 5, 10 and 16 years to determine long-term 
effects of infancy iron supplementation. At 16 years, they were invited to participate in a 
study of biopsychosocial determinants of obesity and cardiovascular risk.  
Sample. For the current analysis, we included 577 adolescents (299 males and 278 
females) seen at 16 years and who weighed <4 kg at birth and had complete data on 
adolescent adiponectin. The analytic sample did not vary from the overall sample with 
respect to: sex, age of first bottle of formula/cow milk, length and weight at 6 months. The 
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analytic sample weighed less at birth (3.4 vs 3.7 kg) and had a lower birth length (50.4 vs 
51.3 cm) compared to the overall sample, a difference related to the exclusion criteria of 
weighing ≥4 kg at birth. The analytic sample included participants who did not received 
(n=235) and who received iron supplementation (high iron group: n=283; low iron group, 
n=13) during infancy; iron supplementation group was considered as a covariate in the 
multivariate models.   
Infancy data. Beginning at 4-6 months, infants were followed with monthly 
anthropometric measurements at the Institute of Nutrition and Food Technology (INTA), 
University of Chile; previous anthropometric data (i.e. birth to the recruitment age) were 
obtained from medical records. Changes in weight-for-age Z score (WAZ-score) between 
birth and 6 months (∆0-6 WAZ-score) were computed as the difference between WAZ-
scores at 6 months and birth (according to WHO, using AnthroPlus Software). For those 
receiving formula/cow milk supplementation to breastfeeding at 4 months, the date of the 
first bottle was recorded based on maternal report (n=298). For all other infants (n=256), 
this information was obtained prospectively. The duration of breastfeeding as the sole 
source of milk (BF) was computed. Shorter BF was defined as supplementation prior to <6 
months (cutoff chosen given Chilean pediatricians’ recommendation). We did not collect 
data on introduction of complementary food (pureed fruits were typically introduced after 4 
months) (18), nor do we have data on consumption of water or fruit juices. Thus, in our 
study, infants may have received water or juice and almost certainly received 
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complementary foods after 4 months. Therefore, BF is not equivalent to exclusive 
breastfeeding as defined by WHO (19). 
Adolescent data. Participants were assessed, after an overnight fast, by trained 
medical professionals at INTA. Participants were weighed and measured twice in the 
Frankfurt position wearing underwear and without shoes. Body mass index (BMI) z-score 
were computed using WHO standards (using AnthroPlus Software). BMI z-scores were 
used to classify participants as normal weight (z-score <1), overweight (z-score ≥1 to <2), 
or obese (z-score ≥2). Body composition was assessed using Lunar Prodigy Dual Energy 
X-Ray Absorptiometry scan, according to standard protocols. Body fat mass was used for 
computing fat mass index (fat mass [kg]/ height [m]2). Fasting blood samples were 
processed, stored (-80°C), and analyzed at the Micronutrient Laboratory, INTA, following 
standard quality assurance and quality control procedures. Glucose and high-density 
lipoprotein cholesterol (HDL-c) were measured using enzymatic-colorimetric tests (QCA 
S.A. Amposta, Spain). Insulin was determined by radioimmunoassay I125 (Siemens 
Healthcare diagnostic Inc). Adiponectin was determined by enzyme-linked immunosorbent 
assay (ELISA) Quantikine®, with a minimum detectable concentration ranging from 
0.079–0.891 ng/mL. Criteria from the International Diabetes Foundation (IDF) were used 
to define altered HDL-c (˂ 40 mg/dL for males, <50 mg/dL for females) (20). Altered 
homeostatic model assessment of insulin resistance (HOMA-IR) was defined by local 
criteria as greater than 3.3 (21). The study was approved by the Institutional Review Boards 
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of the University of California, San Diego for the adolescent wave and of the University of 
Michigan and INTA, University of Chile, for all waves of the study. Adolescent assent and 
parental consent were obtained.  
Statistical Analysis. All continuous variables were tested for normality and were 
described as mean (standard deviation) or median (interquartile range). Categorical 
variables were expressed as percentages. Comparisons between weight status (normal, 
overweight, obese) were stratified by sex and tested using ANOVA and Kruskal-Wallis 
(post-hoc comparisons) or Chi-square tests. Adiponectin levels were grouped according to 
sex and weight status for density curves construction, which are similar to histograms but 
allow smoothing the curve and model the probability of having a specific value on the x-
axis (see Supplementary Information). Logistic regressions were performed to explore the 
association between adolescent adiponectin levels and concomitant insulin-resistance or 
altered HDL-c, adjusted for sex and fat mass index. In both models, we tested for an 
interaction between sex and adiponectin. The interaction was not statistically significant 
and was removed for parsimony. A multivariate linear regression model was used to study 
the association between early life factors (∆0-6 WAZ-score and short BF) and adolescent 
adiponectin values, adjusting for fat mass index and adolescent hemoglobin levels (given 
the recently reported association between iron status and adiponectin levels (22). The initial 
linear model also considered other covariates such as sex, maternal education (as a proxy of 
social economic status), and iron supplementation group at infancy (received iron 
supplementation yes vs no), but were removed for parsimony since they did not 
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significantly influence (<10%) the magnitude of the studied associations. Additionally, we 
have confirmed the findings with a sensitivity analysis including only participants in the 
no-iron treatment group (data not shown). The potential interaction between BF and early 
weight gain was also studied and discarded. Results were considered as statistically 
significant when p-value <0.05. Analyses and graphs were performed using STATA 12 
(STATA Corp., College Station, TX). 
 
Results 
 
This analysis included 577 adolescents (48.2% female). The mean weights were 
3.44±0.27 kg at birth (WAZ-score=0.3±0.6), and 7.97±0.87 kg at 6 months (WAZ-score= 
0.3±0.9). Thus, the mean WAZ-score did not change between birth and 6 months. The 
median age of the first milk/formula bottle was 92 [31-180] days; 74.7% of the sample 
received the first bottle before 6 months. Adolescents averaged 16.8±0.3 years of age, 
ranging from 16.4 to 18.1y; 23.7% of the sample was overweight and 13.9% was obese.  
As shown in Table 1, females who were obese in adolescence had higher WAZ-
scores at birth and 6 months, compared to their normal weight counterparts (WAZ-score 
birth: 0.31±0.54 vs 0.57±0.63; and WAZ-score 6m: 0.18±0.76 vs 0.53±0.78 for normal 
weight vs obese, respectively; both p-values<0.05). However, changes in WAZ-score 
between birth and 6 months were similar between the different weight status groups (-
0.14±0.83 vs 0.01±0.84 for normal weight vs obese, respectively; p-value>0.05). Among 
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males, infant anthropometric parameters did not differ by adolescent weight status (WAZ-
score birth: 0.22±0.55 vs 0.35±0.54 for normal weight vs obese, respectively; p-
value>0.05). Age at the first milk/formula bottle did not differ by sex (117.9±101.5 vs 
117.1±97.1 for males vs females, respectively; p-value>0.05) or adolescent weight status 
(113.1±86.4 vs 133.1±97.1 for normal weight vs obese, respectively; p-value>0.05).   
Compared to normal weight participants, obese participants had significantly higher 
insulin, HOMA-IR and lower HDL-c; overweight participants had significantly higher 
insulin and HOMA-IR; only overweight males had lower HDL-c (Table 1). Adiponectin 
levels were lower in those with higher adiposity and differed by weight status and sex. 
Both, overweight and obese males had significantly lower adiponectin levels than normal 
weight males. Obese females had significantly lower adiponectin levels than 
overweight/normal weight females (Table 1). Density curves describe these differences and 
illustrate the wide range of values in each weight category (Supplemental Figure 1).  
Adiponectin levels were inversely and independently associated with metabolic 
disturbances. Higher adiponectin levels were associated with decreased odds of having 
altered HOMA-IR and HDL-c, after controlling for fat mass index and sex (Table 2). 
Results were similar when adjusting for BMI, rather than fat mass index (results not 
shown). This association was not found for other cardiometabolic variables, such as blood 
pressure, triglycerides or LDL-c (data not shown). There were no interactions between 
adiponectin levels and either fat mass index or sex.  
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Adolescent adiponectin level was independently associated with BF duration and 
weight gain during the first 6 months of life, taking into account sex and adolescent 
adiposity (Table 3). Being breastfed as the sole source of milk for ˂6 months was 
independently associated with lower adolescent adiponectin levels. Participants with short 
BF had 1.58 ug/mL lower adiponectin levels compared to participants with long BF, 
adjusting for early weight gain, adolescent fat mass index and hemoglobin. Changes in 
WAZ-score between birth and 6 months were also independently and significantly 
associated with lower adolescent adiponectin levels. Adiponectin levels were 0.88 ug/mL 
lower per each unit increase of WAZ in the first 6 months, adjusting for BF, adolescent fat 
mass index and hemoglobin).  
 
Discussion 
 
In a cohort of healthy Chilean adolescents, we studied adiponectin levels, their 
metabolic correlates and early-life determinants. We found that adiponectin levels exhibited 
wide and overlapping ranges across the three weight status groups and higher adiponectin 
levels were associated with decreased metabolic disturbance, taking fat mass and sex into 
account. The inverse association of adiponectin with various measures of adiposity is well 
established in both adults and children/adolescents (23, 24). However, the heterogeneity of 
adiponectin levels within each weight status group (Supplemental Figure 1) has garnered 
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less attention. The variability of adiponectin levels unexplained by weight status highlights 
the need to identify additional factors associated with adiponectin concentrations, 
especially given its cardiovascular protective effect. The associations we observed between 
low adiponectin levels and cardiovascular risk factors, independent of fat mass or sex, is 
consistent with previous research. Volberg et al. showed similar positive associations 
between adiponectin and HDL-c, and negative associations between adiponectin and 
triglycerides and blood pressure among ∼150 9-year-old children, adjusting for BMI (10). 
Other reports have shown similar independent associations between adiponectin and lipids 
or other metabolic parameters (11). Moreover, Weghuber et al. implicated adiponectin 
levels, among other factors, as responsible for the distinction between metabolically healthy 
and unhealthy overweight/obesity in youth (25). The results of our study and those of 
others suggest that differences in adiponectin levels may be related to the development of 
metabolic disturbances. Thus, adiponectin -either by itself or as a marker of AT 
dysfunction- is an important player in the concordance (or discrepancy) between fat mass 
and metabolic performance.  
We were also interested in studying early life predictors and found that greater 
WAZ-score gain in the first 6 months of life and duration of BF <6 months, were 
independently associated with lower adiponectin levels. This information is in line with 
previous reports of greater early weight gain and early formula or cow milk as risk factors 
for later development of non-communicable diseases (23, 26). Volberg et al. also studied 
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the association of perinatal factors with adiponectin levels and found that infant weight gain 
during the first 6 months was inversely associated with adiponectin levels at 9 years, 
adjusting for child BMI (n=146) (10). Infant nutrition was not included in their analysis. 
Volberg et al. also found that intrauterine growth influenced later adiponectin values. 
Larnkjaer et al. similarly (14) found that WAZ-score changes during the first 3 months 
were inversely related to adolescent adiponectin levels (divided by fat mass [kg]), taking 
breastfeeding into account (n=95). Our results replicate their observations in a considerably 
larger sample. Most available studies have controlled for child BMI. Our study has the 
additional strength of having data on fat mass measured by DXA scan, which is an 
improvement on BMI adjustment because the latter is an indirect assessment of fat mass 
and thus is not an accurate measure of adiposity. One other prior study reported an 
association between breastfeeding and higher levels of high molecular weight adiponectin, 
which is a specific form of total circulating adiponectin (15). In 12-month-old infants 
(n=99), de Zegher et al. found that formula-fed small-for-gestational-age infants had lower 
adiponectin levels than breast-fed small-for-gestational-age infants at 4 and 12 months. For 
our study, there is no data on intrauterine growth, and by design, our cohort excluded low 
birth weight or small-for-gestational-age infants.  
Since breastfed infants gain more weight during the first 6 months (27), it is worth 
noticing that both early factors were associated with adiponectin levels independently of 
each other. Thus, on one hand greater early weight is associated with lower adolescent 
adiponectin levels, regardless of the source of milk, and on the other hand, breastfeeding is 
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associated with greater adiponectin levels, even when considering the potential differences 
in early weight gain. Moreover, both early factors were associated with adolescent 
adiponectin levels after taking into account fat mass index (among other covariates). This is 
relevant since both factors have been associated with later adiposity (28-30). Furthermore, 
given recent findings related to the association between iron and adiponectin levels (22) 
and because of the design of the original study, we also included both infancy iron 
supplementation group and adolescent hemoglobin level in the models. Only the latter was 
relevant in the studied model. 
Our study was unable to evaluate potential mechanisms involved in the deleterious 
influences of greater weight gain and shorter BF on adolescence adiponectin levels. Since 
body composition was not measured during infancy, we cannot assess the role of greater fat 
mass gain in early life. However, previously reported data suggests that both greater weight 
gain and shorter BF are associated with greater fat mass gain as early as 2 years (24). If this 
were the case among our participants, it would be plausible to hypothesize that the greater 
expansion of AT during a determined window of time could constitute a “biological 
challenge” that impaired AT functionality. Adolescent adiponectin levels may reflect long-
term consequences of such early biological changes in AT physiology. Future studies on 
the topic should focus on body composition changes in early life and throughout childhood 
(i.e. assessment of fat vs. lean mass gain) in order to better understand the dynamics of AT 
expansion and its consequences. Additionally, future studies could also address AT 
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functioning in a more comprehensive way by studying, for example, topography of fat 
deposit (i.e. subcutaneous vs intra-abdominal) and/or other adipokines levels.  
There are additional limitations and important strengths of our study. Some 
participants received iron supplementation treatment during infancy, which could be 
associated with future adiponectin levels. We considered treatment group and adolescent 
iron status in multivariate models, but some residual confounding might still be present in 
the association. Furthermore, findings from our cohort of low- to middle-income Chilean 
adolescents, studied since infancy, may not be generalizable to individuals from other 
backgrounds. SES was not associated to either predictors or the dependent variables (data 
not shown). We hypothesize that because we do not have the full range of SES represented 
in our sample, we were unlikely to find any confounding associations with SES. In 
addition, maternal obesity, a known predictor of infant and adolescent weight gain, was not 
collected. The strengths of the study include the large infancy cohort with longitudinal data 
into adolescence, anthropometry measured at a nutrition research center, careful 
measurement of infant breast and bottle feeding, and the availability of data on adolescent 
body composition, measured by DXA scan. Breastfeeding, is often recalled years later, 
which could lead to under- or over-reporting of duration. Having prospectively collected 
breastfeeding data provides confidence in describing findings using a cut-off value (<6 
months versus ≥6 months).  
In our study of 577 Chilean adolescents studied since infancy, participants with 
lower levels of adiponectin were more likely to have insulin resistance and/or low HDL-c. 
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Weight status and sex alone did not adequately explain individual adiponectin levels. Early 
life factors including greater weight gain in the first 6 months and shorter BF were 
independently associated with lower adiponectin levels. Our findings regarding the 
influences of early postnatal factors on adiponectin levels and the associations of this 
hormone to metabolic parameters adds evidence that early life factors are related to later 
metabolic health, supporting the developmental origin of health and disease paradigm.  
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Table 1. Descriptive data according to weight status and sex (N=577).  
 Males Females 
 Normal weight  
(n=193) 
Overweight 
(n=65) 
Obese 
(n=41) 
Normal weight 
(n=167) 
Overweight 
(n=72) 
Obese 
(n=39) 
Infancy Data       
WAZ-score birth 
WAZ-score 6m+ 
∆0-6 WAZ-score+ 
Age of first bottle 
[days]++ 
0.22 (0.55) 
0.19 (0.88) 
-0.04 (0.93) 
115.40 (92.41) 
0.29 (0.52) 
0.44 (0.98) 
0.15 (0.92) 
118.48 (110.63) 
0.35 (0.54) 
0.47 (0.93) 
0.09 (0.94) 
128.59 (126.84) 
0.31 (0.54)a 
0.18 (0.76)a 
-0.14 (0.83) 
110.84 (78.95) 
0.40 (0.55)a 
0.45 (0.83)a 
0.07 (0.82) 
116.14 (101.77) 
0.57 (0.63)b 
0.53 (0.78)b 
0.01 (0.84) 
139.44 (120.95) 
Adolescent Data 
BMI z-score -0.16 (0.79)a 1.44 (0.30)b 2.54 (0.43)c -0.03 (0.69)a 1.42 (0.27)b 2.57 (0.52)c 
Fat mass index [kg/m2] 3.63 (1.33)a 7.29 (1.57)b 11.58 (2.18)c 6.80 (1.52)a 10.68 (1.39)b 15.26 (2.65)c 
Adiponectin [ug/mL] 11.06 (4.94)a 8.90 (4.50)b 7.80 (4.15)b 13.42 (5.70)a 12.32 (4.62)a 9.04 (4.64)b 
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Values indicate either mean (SD), median (IQR) † or percentage ‡. 
a,b,c – Differing letters indicate significant differences between weight-status groups, within sex (ANOVA/Bonferroni or Kruskal-
Wallis/ Bonferroni). Values that do not differ by weight-status group, within sex, are indicated by matching letters. 
* indicates p-value<0.05 between weight status within each sex (Chi square). 
HOMA-IR ≥3.3, altered HDL-c: 4˂0 mg/dL for males and 50 mg/dL for females. 
+ N=526 
++N=574 
Glucose [mg/dL] 90.52 (8.61) 90.30 (9.30) 94.41 (14.54) 85.98 (9.00) 86.71 (9.98) 88.89 (8.99) 
Insulin [µUI/dL]† 5.30 (3.99-7.54)a 7.85 (4.84-11.18)b 11.76 (9.09-19.22)c 6.40 (4.43-8.20)a 7.37 (5.91-10.88)b 11.43 (9.11-17.30)c 
HOMA-IR† 1.21 (0.85-1.73)a 1.81 (1.09-2.39)b 2.85 (1.85-4.74)c 1.33 (0.92-1.79)a 1.61 (1.22-2.32)b 2.46 (1.83-4.05)c 
HOMA-IR ≥ p75 [%]‡ 1.6 9.2 43.9* 1.8 9.7 35.9* 
HDL-c [mg/dL] 40.33 (10.01)a 35.04 (9.18)b 31.06 (6.24)b 44.08 (11.63)a 42.70 (9.72)a 37.17 (7.47)b 
Altered HDL-c [%]‡ 54.4 73.8 95.1* 68.9 75.0 94.9* 
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Table 2. Association between adiponectin level and altered HOMA-IR and altered HDL-c in 
adolescence 
 
 
 
 
 
Two different logistic regression models are presented, using adiponectin as predictor and 
adjusting for covariates (sex and fat mass index).  
Values correspond to OR (95% confidence interval) in 2 different logistic regressions. 
*P-value<0.05 
# N=576 
Ψ N=577 
 
 
 
 
 
 
 
 Altered HOMA-IR # Altered HDL-c Ψ 
Adiponectin 0.87 (0.79-0.95)* 0.90 (0.87-0.94)* 
Female 0.36 (0.17-0.78)* 0.83 (0.54-1.25) 
Fat mass index 1.41 (1.28-1.54)* 1.08 (1.03-1.14)*  
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Table 3. Association between early life factors and adolescent adiponectin levels (N=526)* 
 
 
 
 
* Model adjusted for adolescent fat mass index and hemoglobin levels  
R2=0.07 (p-value<0.05) 
 
 
 
 
 
  
 
 
 
 Beta p-value 
Breastfed ˂ 6 mo -1.58 0.004 
∆0-6 weight-for-age -0.88 0.002 
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